Claus Lindbjerg Andersen

38PUBLICATIONS
186CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersCancer geneticsMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|May 05, 2026
Neoadjuvant Single-Cycle Pembrolizumab for Stage I-III MMR-Deficient Colon Cancer: The RESET-C Trial.

|Mar 25, 2026
Cell-Free DNA-Derived Immune Cell Ratios Uncover Cancer-Associated Systemic Changes.

Laura Andersen, Sia V Lindskrog, Iver Nordentoft

|Feb 12, 2026
The impact of time-to-recurrence on post-recurrence mortality in stage I-III colorectal cancer: A nationwide Danish cohort study.

Jesper Nors, Kåre Andersson Gotschalck, Rune Erichsen

|Feb 10, 2026
Molecular residual disease assessment in colorectal and bladder cancer by somatic structural variant analysis of cell-free DNA whole-genome sequencing data.

Ester Ellegaard Sørensen, Amanda Frydendahl, Mads Heilskov Rasmussen

|Nov 21, 2025
Cross-dataset pan-cancer detection by correlating cell-free DNA fragment coverage with open chromatin sites across cell types.

Ludvig Renbo Olsen, Denis Odinokov, Jakob Qvortrup Holsting

|Nov 14, 2025
Perspectives in educating molecular pathologists on liquid biopsy: Toward integrative, equitable, and decentralized precision oncology.

Marius Ilié, Umberto Malapelle, Catherine Alix-Panabières

Pageof 7

Frequent Collaborators

11 joint publications

Jesper Nors

9 joint publications

Kåre Andersson Gotschalck

9 joint publications

Amanda Frydendahl

8 joint publications

Mads Heilskov Rasmussen